Drug and Therapeutics Bulletin 1995;33:30-32; doi:10.1136/dtb.1995.33430
Copyright © 1995 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Dopexamine after cardiac surgery

Relevant BNF section: 2.7.1

After heart surgery there may be many hours in which cardiac output is reversibly depressed. Treatment is given to enhance output and to ensure an adequate blood supply to vital organs. Drugs used in this situation commonly include dopamine and dobutamine. Dopexamine (Dopacard-Speywood) is a dopamine analogue which in the UK is licensed only for the short-term treatment of patients with low cardiac output after heart surgery. The manufacturer claims that dopexamine is particularly effective in promoting renal and splanchnic blood flow. Is dopexamine an advance on dopamine and dobutamine?






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1995 BMJ Publishing Group Ltd.